Skip to content

Insider · CIK 0001845681

Travis Murdoch

ceopresidentofficerdirector

Files at BRVE (Braveheart Bio, Inc.). First filing Aug 7, 2026, latest Aug 7, 2026.

In brief

Travis Murdoch files SEC Form 4 as CEO, president and director at BRVE (Braveheart Bio, Inc.). Since Aug 7, 2026, Travis Murdoch has reported 1 open-market buy worth $1.5M and 0 open-market sells worth $0, the latest filed on Aug 7, 2026.

A track record needs three past buys with six months of prices behind them; Travis Murdoch has 0, so none is measured yet.

The newest scored trade: bought $1.5M of BRVE on Aug 7, 2026, filed Aug 7, 2026, scored 65 (notable). In the last 12 months: 1 buy worth $1.5M and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$1.5M bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

BRVE: Braveheart Bio, Inc.

BRVEOct 13, 2026 · close 19.33

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
65Notable
BRVEbuy 10
Braveheart Bio, Inc.
$1.5M
83,333 shares
+3%-

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 7, 2026BRVE
Braveheart Bio, Inc.
POpen-market purchase
Common Stock
+83,333$18.00$1.5M2,940,670Aug 7, 2026
Aug 5, 2026BRVE
Braveheart Bio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+550,000$0.00$0550,000Aug 7, 2026

Questions about Travis Murdoch

Answered from the filings on this page, as of the latest one.

Is Travis Murdoch buying or selling?

In the last 12 months Travis Murdoch reported 1 open-market buy worth $1.5M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $1.5M of BRVE on Aug 7, 2026. Grants, option exercises and tax withholding are not counted.

How did Travis Murdoch's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Travis Murdoch has 0.

Where does Travis Murdoch file Form 4?

Travis Murdoch has filed Form 4 at BRVE (Braveheart Bio, Inc.) as CEO and President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.